💊 mRNA money spreads wings around the world; Biogen worries multiply; What about long Covid?

Feb 17, 2022

∙ Paid

In today’s issue: Shining the spotlight on BioNTech’s Africa plans; Moderna expands more; Molnupiravir not likely in the EU; Aduhelm’s woes continue; The “long Covid” crisis; Covid and the immunocompromised; A return to normal in Australia

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.